AB
Arbutus Biopharma Corp
🇩🇪XFRA.I9DNGermanyHealthcare
€4.37EURup +0.01 (+0.23%)OpenEnd of day7:52 PM
Price€4.37+0.01 (+0.23%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- CA03879J1003
- CUSIP
- Not reported
Company
- Employees
- 19
- Headquarters
- Warminster, United States
- Website
- https://www.arbutusbio.com
- CEO
- Ms. Lindsay Androski J.D., M.B.A.
Market
- Shares outstanding
- 198.1M
- Market cap
- €865.72M
Key dates
- Next earnings
- Nov 16, 2026
Highlights
No high and low reported for today's session.
- Market cap
- €865.72M
- EPS LTM
- $0.77calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $181.72M+1,078.78%up year on year
- Net income
- $153.05M+382.12%up year on year
- Gross margin
- 99.98%+752%up year on year
- Free cash flow
- -$24.63M+59.15%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.